TY  - JOUR
AU  - Gebhardt, Christoffer
AU  - Sevko, Alexandra
AU  - Jiang, Huanhuan
AU  - Lichtenberger, Ramtin
AU  - Reith, Maike
AU  - Tarnanidis, Kathrin
AU  - Holland-Letz, Tim
AU  - Umansky, Ludmila
AU  - Beckhove, Philipp
AU  - Sucker, Antje
AU  - Schadendorf, Dirk
AU  - Utikal, Jochen
AU  - Umansky, Viktor
TI  - Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab.
JO  - Clinical cancer research
VL  - 21
IS  - 24
SN  - 1557-3265
CY  - Philadelphia, Pa. [u.a.]
PB  - AACR
M1  - DKFZ-2017-02603
SP  - 5453 - 5459
PY  - 2015
AB  - Immunotherapy with ipilimumab improves the survival of patients with metastatic melanoma. Because only around 20
KW  - Antibodies, Monoclonal (NLM Chemicals)
KW  - Antineoplastic Agents (NLM Chemicals)
KW  - Biomarkers (NLM Chemicals)
KW  - Inflammation Mediators (NLM Chemicals)
KW  - ipilimumab (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:26289067
DO  - DOI:10.1158/1078-0432.CCR-15-0676
UR  - https://inrepo02.dkfz.de/record/126575
ER  -